⌘K

Login Start Free

Home/Filings/4/0001140361-11-054351

4//SEC Filing

Romm Preston S 4

Accession 0001140361-11-054351

CIK 0001375247other

View on SEC.gov Company Profile

Filed

Nov 17, 7:00 PM ET

Accepted

Nov 18, 4:44 PM ET

Size

22.1 KB

Accession

0001140361-11-054351

Insider Transaction Report

Form 4

Period: 2011-11-16

Obagi Medical Products, Inc.OMPI

CFO

Transactions

Sale
Common Stock
2011-11-16$9.92/sh−1,300$12,898→ 0 total
Exercise/Conversion
Common Stock
2011-11-18$5.86/sh+13,179$77,229→ 13,179 total
Sale
Common Stock
2011-11-16$9.97/sh−8,286$82,607→ 1,300 total
Exercise/Conversion
Common Stock
2011-11-17$5.86/sh+10,569$61,934→ 10,569 total
Sale
Common Stock
2011-11-17$9.67/sh−4,369$42,251→ 0 total
Exercise/Conversion
Employee Stock Option (right to buy)
2011-11-16−9,586→ 40,414 total
Exercise: $5.86Exp: 2019-03-03→ Common Stock (9,586 underlying)
Sale
Common Stock
2011-11-17$9.95/sh−5,600$55,720→ 4,969 total
Exercise/Conversion
Common Stock
2011-11-16$5.86/sh+9,586$56,174→ 9,586 total
Sale
Common Stock
2011-11-17$9.78/sh−600$5,870→ 4,369 total
Sale
Common Stock
2011-11-18$9.72/sh−13,179$128,056→ 0 total
Exercise/Conversion
Employee Stock Option (right to buy)
2011-11-17−10,569→ 29,845 total
Exercise: $5.86Exp: 2019-03-03→ Common Stock (10,569 underlying)
Exercise/Conversion
Employee Stock Option (right to buy)
2011-11-18−13,179→ 16,666 total
Exercise: $5.86Exp: 2019-03-03→ Common Stock (13,179 underlying)

Footnotes (1)

[F1]Fully vested and immediately exercisable.

Documents

1 file

4
doc1.xmlPrimary
FORM 4

Issuer

Obagi Medical Products, Inc.

CIK 0001375247

Entity typeother

Related Parties

1

filerCIK 0001359475

Filing Metadata

Form type: 4
Filed: Nov 17, 7:00 PM ET
Accepted: Nov 18, 4:44 PM ET
Size: 22.1 KB

View on SEC.gov